Clinical Trial Update: Effect of Ranolazine on Activity Level in Patients With Angina After FFR Based Deferred Intervention (REPTAR) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the effect of ranolazine on activity level in patients with angina after FFR-based deferred intervention (REPTAR). The d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina

Drugs mentioned

• Ranexa (ranolazine)

Snippet

Sponsor: Amit Malhotra, MD | Conditions: Angina | Phase 4 | Status: UNKNOWN